1. Korean Intellectual Property Tribunal (KIPT) adopts “oral argument “as a trial method
The KIPT announced on January 28 that the trial method of the KIPT would be changed from “the writtendocument proceeding” into “the oral proceeding”. The oral proceeding amounts to the oral pleadings at the litigation court, in which both parties attend the proceeding and make oral arguments before a panel of 3 judges(chief judge, head judge and associate judge ) to make the issues clear and enhance the acceptability of the trial decision.
For this, the KIPT has increased the number of a trial court from current one to five and reinforced 3 court staffs for preparing and recording oral proceeding and 4 stenographers.
The KIPT also plans to revitalize the ‘selfjudging system’ by which a trial examiner can make a decision early on the applicant’s right of the patent through the patent in person, and to extend the subjects of ‘prompt trial’ in which trial decision is promptly made within 4 months.
The subjects of prompt trial include the trial cases related to green technologies, the trials for confirming the scope of rights in connection with the litigations on infringement, and the trials for correction filed during the trial for patent invalidation.
2. Novartis has filed the most patent applications in the field of medication
Statistics on PCT and Madrid Protocol applications in 2009
Novartis has filed the most patent applications in the field of medication last year with 62 applications, according to the ‘Statistics on PCT and Madrid Protocol Application’ published by Statistics Korea on February 2.
According to the statistics, domestic filings in the field of medication reached 910 cases in 2009, which decreased by 23.1% compared to the previous year.
Reviewing in more detail, Novartis of Switzerland filed the most with 62 applications followed by Sanofi Aventis with 51 applications.
Also, the number of the international application by foreign applicants in Korea via Madrid Protocol reached 7,824 cases which decreased by 19.7% compared to 9,745 cases of the previous year. This decrease in the international applications seems to reflect the current global economic downturn, said the KIPO.